title: Preclinical versus clinical neuroprotection.
authors.affiliation: Department of Neurochemistry, Clinic and Polyclinic of Psychiatry and Psychotherapy, Bayerische Julius-Maximilians-University of Würzburg, Würzburg, Germany.
authors.forename: Edna
authors.initials: E
authors.lastname: Grünblatt
authors.forename: Robert
authors.initials: R
authors.lastname: Schlösser
authors.forename: Manfred
authors.initials: M
authors.lastname: Gerlach
authors.forename: Peter
authors.initials: P
authors.lastname: Riederer
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D002986:Clinical Trials as Topic; D018491:Dopamine Agonists / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology
chemical_list: D000975:Antioxidants; D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D018691:Excitatory Amino Acid Antagonists; D008996:Monoamine Oxidase Inhibitors; D018696:Neuroprotective Agents